|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-14
|
|
pubmed:abstractText |
Dose-limiting toxicity of many newer chemotherapeutic agents is peripheral neuropathy. Prior attempts to reduce this side effect have been unsuccessful. We report on the possible successful reduction of peripheral neuropathy with glutamine administration after high-dose paclitaxel.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AntmanKK,
pubmed-author:BagiellaEE,
pubmed-author:BalmacedaCC,
pubmed-author:DonovanDD,
pubmed-author:FrederickDD,
pubmed-author:GarrettTT,
pubmed-author:HesdorfferC SCS,
pubmed-author:KaufmanEE,
pubmed-author:LangeDD,
pubmed-author:LeuinSS,
pubmed-author:NicholsGG,
pubmed-author:PapadopoulouEE,
pubmed-author:SavageDD,
pubmed-author:TierstenAA,
pubmed-author:VahdatLL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1192-7
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11350883-Activities of Daily Living,
pubmed-meshheading:11350883-Administration, Oral,
pubmed-meshheading:11350883-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11350883-Female,
pubmed-meshheading:11350883-Glutamine,
pubmed-meshheading:11350883-Humans,
pubmed-meshheading:11350883-Neural Conduction,
pubmed-meshheading:11350883-Paclitaxel,
pubmed-meshheading:11350883-Peripheral Nervous System Diseases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
|
|
pubmed:affiliation |
Division of Medical Oncology and Hematology, Department of Medicine, The Herbert Irving Comprehensive Cancer Center of Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. vahdat@cuccfa.ccc.columbia.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
